Group 1 - The core point of the article is that Changliang Technology (SZ 300348) held its 30th meeting of the 5th Board of Directors on October 24, 2025, to review the proposal regarding the company's Q3 2025 report [1] - For the first half of 2025, the revenue composition of Changliang Technology is as follows: software development business accounted for 92.07%, maintenance service business accounted for 5.97%, integration accounted for 1.95%, and other businesses accounted for 0.01% [1] - As of the time of reporting, the market capitalization of Changliang Technology is 11.7 billion yuan [1] Group 2 - The article mentions that the Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year [1] - It highlights a conversation with Lu Gang, a partner at Chuangdong Investment, discussing the hot secondary market in biomedicine while the primary market is facing fundraising difficulties [1]

（记者 曾健辉） 每经AI快讯，长亮科技（SZ 300348，收盘价：14.95元）10月10日晚间发布公告称，截至本公告日，王 长春累计质押股数约为2457万股，占其所持股份比例为25.62%。 2025年1至6月份，长亮科技的营业收入构成为：软件开发业务占比92.07%，维护服务业务占比5.97%， 集成占比1.95%，其他业务占比0.01%。 截至发稿，长亮科技市值为121亿元。 每经头条（nbdtoutiao）——天水麻辣烫、淄博烧烤、荣昌卤鹅⋯⋯"泼天流量"退去后，这些城市怎么 样了？ ...

Core Points - The company announced a provision for asset impairment totaling 17.7876 million yuan, which will reduce the consolidated profit for the first half of 2025 by the same amount [1][3] - The company conducted a comprehensive review of its assets as of June 30, 2025, including accounts receivable, inventory, long-term equity investments, fixed assets, and intangible assets, to assess the recoverability of these assets [3] Revenue Composition - For the year 2024, the revenue composition of the company is as follows: software development accounts for 85.77%, integration services for 9.5%, maintenance services for 4.71%, and other businesses for 0.02% [1]